• Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    France Hungary Poland Romania Spain
  • Study of Pembrolizumab, Favezelimab, and Lenvatinib for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Italy Poland Spain
  • Study on Budigalimab and ABBV-382 for People with HIV on Stable Antiretroviral Therapy

    Not recruiting

    2 1
    Investigated diseases:
    Belgium Denmark France Germany Italy Poland +1
  • Study of Chemotherapy and Nivolumab Before and After Surgery for Patients with Non-Small Cell Lung Cancer in the Upper Lung Area

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Spain
  • Study on Lidocaine, Ropivacaine, and Epinephrine for Patients Undergoing Hand Surgery with Ultrasound-Guided Nerve Block

    Not recruiting

    3 1 1 1
    Denmark
  • Study of Pembrolizumab, Carboplatin, and Paclitaxel for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Austria France Germany Poland Romania Spain
  • Study Comparing Brimonidine and Timolol Eye Drops for Patients with Open-Angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Greece
  • Study on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Czechia France Germany Hungary Italy +2
  • Study on Lasmiditan for Treating Migraine in Children Aged 6 to 17

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Romania +1
  • Study of Ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Germany Hungary Italy Poland +2

powered by